[IMA-HelenT]

The substack : https://www.malone.news/p/the-cias-war-on-oversight

[IMA-HelenT]

FULL STATEMENT: Washington, D.C. — May 13, 2026 — The Independent Medical Alliance (IMA) today announced the publication of the latest edition of the Journal of Independent Medicine (JIM), continuing the journal’s mission to provide a rigorous, conflict-free platform for scientific inquiry, clinical debate, and evidence-based medicine free from pharmaceutical or political influence.

The May 2026 issue features a wide range of peer-reviewed articles spanning critical care, public health, medical ethics, integrative medicine, vaccine safety, autism research, respiratory disease, and healthcare reform. Headlining the issue is a major review article, “Determinants of Autism Spectrum Disorder,” authored by researchers affiliated with the McCullough Foundation and led by Dr. Peter A McCullough, MD, MPH, examining genetic, environmental, prenatal, and iatrogenic contributors to autism spectrum disorder.

“One of the fundamental responsibilities of scientific publishing is to allow important questions to be examined openly and rigorously—even when those discussions are uncomfortable,” said Dr. Joseph Varon, Editor-in-Chief of the Journal of Independent Medicine and President of the Independent Medical Alliance. “The Journal of Independent Medicine exists to ensure that clinicians and researchers have a credible, double-blind peer-reviewed platform where scientific evidence can be debated transparently and without fear of institutional suppression. Honest Medicine requires intellectual courage, methodological rigor, and a willingness to follow the data wherever it leads.”

Now in its second year of publication, the Journal of Independent Medicine continues to expand its global reach and scholarly impact, publishing work from physicians, researchers, and healthcare professionals across multiple disciplines and countries.

“We continue to be encouraged by the caliber of submissions coming from experts around the world who believe medicine advances through open scientific discourse—not ideological conformity,” Dr. Varon added. “Every article published in the Journal undergoes a rigorous double-blind peer-review process and is evaluated on scientific merit alone. At a time when public trust in medical institutions remains fragile, independent journals committed to transparency and critical inquiry are more important than ever.”

Featured Articles in the May 2026 Edition

• Determinants of Autism Spectrum Disorder

Nicolas Hulscher; John S. Leake; Simon Troupe; Claire Rogers; Kirstin Cosgrove; M. Nathaniel Mead; Breanne Craven; Mila Radetich; Andrew Wakefield; Peter A. McCullough

A comprehensive review examining genetic, environmental, prenatal, and iatrogenic contributors to autism spectrum disorder and calling for expanded research into cumulative neurodevelopmental risk factors.

• The ACIP Committee: A Seat at the Table and a Responsibility to Speak

Joseph Varon, MD

A commentary reflecting on IMA’s appointment to the Advisory Committee on Immunization Practices (ACIP) and the importance of transparency, physician agency, and evidence-based dialogue in public health policy.

• The Additive Role of Alternative Therapies in Modern Medicine: The Good, the Bad, and the Ugly

Adylle T. Varon, Joseph Varon

Explores how alternative therapies may complement conventional medicine while emphasizing the importance of evidence, regulation, and clinical oversight.

• Healthcare: A Wake-Up Call to Reclaim Excellence – Empowering the Next Generation of Physicians, Dentists, and Allied Healthcare Professionals

Jennifer Hibberd

Examines declining standards and burnout in healthcare education and advocates for renewed emphasis on mentorship, excellence, and critical thinking.

• Sepsis Without Biomarkers: A Physiology-Based Approach to Diagnosis and Management in Resource-Limited Settings

Santiago M. Herrero

Presents a practical framework for diagnosing and managing sepsis when laboratory biomarkers are unavailable.

• E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI): A Significant Health Crisis in the Digital World

Rubi Thapa, Vivek Paudyal, Samina Somji, Munish Sharma, Salim Surani

Reviews the rise of vaping-related lung injury and outlines diagnostic challenges, treatment strategies, and prevention considerations.

• Esophageal Cancer Among Gastrointestinal Malignancies in the ICU: Malignancies in the ICU: A Retrospective Analysis of the MIMIC-III Database

Magnolia Donaji Garcia Mendoza, Francesca Martinez-Nachon, Jorge Martinez Muñoz, Joseph Varon

Analyzes ICU outcomes in oncology patients and identifies predictors of mortality and critical illness severity.

• The Relationship Between ROX Index and Inflammatory Markers In COVID-19 Patients

Jorge Martinez, Francesca Martinez-Nachon, Sammy Ghaoui, Paloma A. Molina, Adela Bazbaz, Romina Flores, Joseph Varon

Evaluates whether combining respiratory indices with inflammatory markers improves assessment of disease severity in COVID-19 patients.

• Acquired Tracheobronchomegaly Mimicking Mounier-Kuhn Syndrome Following Prolonged Mechanical Ventilation in Severe COVID-19 ARDS: A Fatal Case

Santiago M. Herrero, Jesús A. Alvarez-Fernández

Describes a fatal airway complication associated with prolonged mechanical ventilation in severe COVID-19 ARDS.

• Chlorine Dioxide as an Adjunctive Treatment in Three Veterinary Cases: A Case Series

Teresa Carr, Mitchell Liester

Reports observational findings from three veterinary cases using chlorine dioxide adjunctively and calls for further controlled research.

• The Claim That COVID-19 Vaccination Protected Australians from All-Cause Mortality Is Not Plausible

Clare M. Pain, Christopher Neil, Mark Jones

Critiques methodological limitations in analyses claiming broad all-cause mortality benefits from COVID-19 vaccination.

All current and past issues of the Journal of Independent Medicine are available free of charge at https://journalofindependentmedicine.org/

About the Journal of Independent Medicine

The Journal of Independent Medicine, published by the Independent Medical Alliance™, is a double-blind peer-reviewed, multi-specialty medical journal dedicated to advancing transparent, evidence-based, and conflict-free scientific inquiry. The journal provides a platform for rigorous clinical research, medical ethics, health policy, and open scientific discussion across a broad range of disciplines

[IMA-HelenT]

Hi @carmen …just in case you hadn’t done an AI search yet, I did, perhaps it will help:

Here are a few strong options that look genuinely experienced with peripheral neuropathy and neuromuscular disorders in the Ohio / Indiana / Michigan / Kentucky region:

Michigan (probably the strongest program regionally)

The University of Michigan has a dedicated Peripheral Neuropathy Program and is considered one of the stronger academic centers in the Midwest for neuropathy evaluation and treatment.

Good specialists there include:

University of Michigan Peripheral Neuropathy Program

Specialists include:

Dr. Amro Stino

Dr. Eva Feldman

Dr. Brian Callaghan

Dr. Benjamin Becker

They handle:

small fiber neuropathy

autoimmune neuropathy

CIDP / GBS

diabetic neuropathy

nutritional neuropathy

post-viral and complex neuropathies

second-opinion cases

📞 Main number: 734-936-9020

https://www.uofmhealth.org/conditions-treatments/brain-neurological-conditions/peripheral-neuropathy-clinic

Indiana

A few neurologists repeatedly came up in patient recommendations:

IU Health Neurology

Mentioned positively for neuropathy care:

Dr. Rusk

Dr. Scheer

Dr. Nevel

Goodman Campbell Brain and Spine

Mentioned by patients as a much better experience than some larger neurology groups.

Ohio

You may want to look specifically at:

Cleveland Clinic Neuromuscular Center

Ohio State Wexner Neurology

Cleveland Clinic in particular is nationally known for neuropathy and neuromuscular disorders, though the Michigan program above may be easier to access depending on wait times.

Kentucky

The strongest likely option would be:

University of Kentucky Neurology

UofL Health Neurology

For more complex or unexplained neuropathy cases, people often still end up referred onward to larger specialty centers like Michigan or Cleveland Clinic.

Honestly, if this is:

unexplained neuropathy

worsening symptoms

small fiber neuropathy

autoimmune suspicion

post-viral / vaccine injury concerns

dysautonomia

burning pain / numbness progressing

…I would personally put University of Michigan Peripheral Neuropathy Program at the top of the list from the states you mentioned. They seem to have the most dedicated neuropathy infrastructure.

[IMA-HelenT]

Please explore our providers list, it is still in it’s infancy but may be helpful: https://imahealth.org/providers/

Here is a link to our guide on red light therapy / photobiomodulation as it may be helpful.

Red light therapy is very commonly discussed in relation to:

peripheral neuropathy

nerve pain

diabetic neuropathy

nerve regeneration

inflammation reduction

circulation improvement

The theory is that red and near-infrared light may help support mitochondrial function, blood flow, and cellular repair in damaged nerves.

There are studies looking at diabetic peripheral neuropathy in particular, with some reporting:

reduced pain

improved sensation

better wound healing

improved circulation

Guide https://imahealth.org/wp-content/uploads/2025/06/ima-red-light-therapy-guide.pdf

[IMA-HelenT]

From Dr. Kat Lindley:

(AI analysis)

A systematic review published in “The Journal of Infectious Diseases” concluded that the overall balance of evidence does not support the claim of human-to-human transmission of the Andes virus (ANDV). While some studies in South America suggested potential transmission, rigorous comparative studies did not support this claim.

Key findings from the study include:

Evidence Evaluation: With the exception of one prospective cohort study with a high risk of bias, stronger comparative studies did not support human-to-human transmission of the Andes virus.

Methodological Concerns: Non-comparative studies that suggested person-to-person spread possessed a critical risk of bias, often failing to rule out co-exposure to the primary, rodent-borne source.

Conclusion: The review, titled “Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review,” calls for better-designed studies and concludes that the evidence does not support the claim of human-to-human transmission of ANDV.

While the Andes virus is unique in its suspected ability for human-to-human transmission, primarily in South America, this specific review determined that the balance of evidence fails to support that claim

Based on the article in The Journal of Infectious Diseases.

[IMA-HelenT]

Another very plausable reason for the panic is the vaccine being developed by Oxford https://www.perplexity.ai/page/hantavirus-vaccine-work-advanc-DFis9OIAQaWa8nvJ6QXc2w?

[IMA-HelenT]

Full article : https://brownstone.org/articles/the-hantavirus-panic-machine-when-rare-diseases-become-media-theater/

[IMA-HelenT]

Good to see someone in charge being balanced

[IMA-HelenT]

Good one @gabby and so glad you can access it again. It’s added as a Second-Line/Adjunctive Therapy in Long Covid Protocol …

It’s also commonly discussed in longevity and autophagy circles because spermidine has been linked in research to:

cellular cleanup/autophagy

mitochondrial support

cardiovascular health

brain aging support

Foods naturally rich in spermidine include:

wheat germ

aged cheese

mushrooms

soy products

legumes

peas

😊

[IMA-HelenT]

Yes, thanks @vegandan really appreciate your perspective as a vegan.

Dr. Carmen addresses this in the guide “Vitamin B12, also known as cobalamin, is mostly found in animal sources of food. So, for
vegans or those who eat a plant-based diet, a B12 supplement is a wise move.”

[IMA-HelenT]

And this webinar would be worth a watch too https://imahealth.org/red-light-therapy-science/

[IMA-HelenT]

The guide does not have study refrences added, however we have an article here https://imahealth.org/tools-and-guides/red-light-therapy-guide/ about the guide, and there are links in that to over 7000 studies … hope that helps.

[IMA-HelenT]

Hi @lainez was it mentioned on the webinar?

[IMA-HelenT]

Thanks @gratitude

Always open to new information.

I suppose my concern is, is it an attempt to “normalise” or even celebrate autism? So people stop pushing for answers.

And I would think it would depend on where your child is on the ‘spectrum’.

But, let’s see if anyone else has some input.

[IMA-HelenT]

@qofmiwok asked Dr. Carmen for a response about flushing, please see below.